First Time Loading...

Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 6.93 AUD -2.39% Market Closed
Updated: Apr 27, 2024

Mayne Pharma Group Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayne Pharma Group Ltd
Net Income (Common) Peer Comparison

Comparables:
RCE
NEU
BOT
PBP
C
CU6

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Mayne Pharma Group Ltd
ASX:MYX
Net Income (Common)
AU$117.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Net Income (Common)
-AU$11.3m
CAGR 3-Years
5%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Net Income (Common)
AU$157.1m
CAGR 3-Years
N/A
CAGR 5-Years
120%
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Net Income (Common)
-AU$14.6m
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
-24%
Probiotec Ltd
ASX:PBP
Net Income (Common)
AU$8.7m
CAGR 3-Years
29%
CAGR 5-Years
-11%
CAGR 10-Years
21%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Net Income (Common)
-AU$24.6m
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mayne Pharma Group Ltd's Net Income (Common)?
Net Income (Common)
117.2m AUD

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Net Income (Common) amounts to 117.2m AUD.